Skip to content

Insider · CIK 0001793200

Sung Lee

cfoofficer

Files at CYTK (CYTOKINETICS INC). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 14, 2025CYTK
CYTOKINETICS INC
AGrant or award
Common Stock
+32,687$0.00$074,442Mar 18, 2025
Mar 14, 2025CYTK
CYTOKINETICS INC
AGrant or award
Incentive Stock Option (Right to Buy)derivative
+9,016$0.00$09,016Mar 18, 2025
Mar 14, 2025CYTK
CYTOKINETICS INC
AGrant or award
Non-Qualified Stock Option (Right to Buy)derivative
+41,326$0.00$041,326Mar 18, 2025
Dec 3, 2024CYTK
CYTOKINETICS INC
AGrant or award
Common Stock
+4,303$0.00$038,987Dec 5, 2024
Dec 3, 2024CYTK
CYTOKINETICS INC
FTax withholding
Common Stock
-1,536$51.51$79k37,451Dec 5, 2024
Dec 3, 2024CYTK
CYTOKINETICS INC
AGrant or award
Common Stock
+4,304$0.00$041,755Dec 5, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Sung Lee: insider trades and track record | InsiderTell